NTI is pleased to announce the appointment of Hugh Sullivan, an innovative leader with deep experience building partnerships and increasing international understanding, as Vice President of Development. Also joining the organization, as a Director for NTI’s Global Biological Policy and Programs (NTI | bio), is David Stiefel, who has a strong background working to increase global action on biosecurity and reduce risks associated with the accidental or deliberate misuse of biology and biological materials.
“We are delighted to have these talented and committed leaders join the NTI team,” said NTI President and Chief Operating Officer Joan Rohlfing. “Hugh and David will bring valuable experience and fresh insights to our work and mission.”
Sullivan comes to NTI after more than a decade at Johns Hopkins University, where he most recently served as Director of International Programs in the Johns Hopkins University’s Office of Development and Alumni Relations, guiding the university and medical institutions’ international fundraising and external affairs. Previously, he was Director of Advancement for Asia at the Johns Hopkins Paul H. Nitze School of Advanced International Studies (SAIS) and the Hopkins-Nanjing Center, a one-of-a-kind graduate joint venture with Nanjing University.
Prior to joining NTI, Stiefel served in the White House as the Director for Biodefense, Deputy Senior Director for Global Health Security and Biodefense, and, most recently, as the Acting Senior Director for Global Health Security and Biodefense on the National Security Council (NSC). At the NSC, David focused on the U.S. government’s strategic approach to countering biological weapons, enhancing pandemic preparedness, and achieving global health security. David led President Biden’s biopreparedness review, which culminated in the signing and release of National Security Memorandum-15 and the National Biodefense Strategy and Implementation Plan.
Sign up for our newsletter to get the latest on nuclear and biological threats.
The cycle of military attack and reprisal is once again dangerously in play in the Middle East. It must be broken before escalation, combined with increasingly destructive technology, one day precludes any hope of peace and security for the region.
A growing coalition of funders is stepping up to ensure that scientific innovation doesn’t come at the cost of safety and security. Representatives from influential, non-governmental funding organizations who advance critical life science research around the world met virtually on May 9, 2025 for the second Bio Funders Forum.
Executive Order 14292 on “Improving the Safety and Security of Biological Research" suggests some promising actions toward protecting modern bioscience and biotechnology against misuse. However, the order threatens to undermine U.S. capabilities to protect the American public from biological threats by requiring a pause in gain-of-function research.
Sign up for regular updates on innovative, real-world solutions to existential threats.
